StonvexLoading…
StonvexStonvexStonvexCore line items from SHAK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q2 2026 2026-04-01 | Annual 2025 2025-12-31 | Q3 2025 2025-09-24 | Q2 2025 2025-06-25 |
|---|---|---|---|---|---|
Revenue | $430.15M | $366.74M | $1.45B | $1.04B | $677.36M |
Operating Income | Not available | $-2.63M | $62.51M | $43.76M | $25.22M |
Net Income | Not available | $-290.00K | $45.73M | $33.89M | $21.39M |
EPS (Diluted) | $0.41 | $-0.01 | $1.09 | $0.81 | $0.51 |
Total Assets | Not available | $1.92B | $1.90B | $1.83B | $1.78B |
Total Liabilities | Not available | $1.36B | $1.34B | $1.29B | $1.26B |
Cash & Equivalents | Not available | $313.65M | $360.12M | $357.76M | $336.80M |
Free Cash Flow OCF − CapEx | Not available | $-38.70M | $56.51M | $52.52M | $28.78M |
Shares Outstanding | Not available | 40.29M | 41.85M | 41.85M | 41.84M |